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Abstract  
The hydroalcoholic extract (BtHA) and its fractions of Bouvardia ternifolia were evaluated as inhibitors of the activity of the acetylcholinesterase enzyme 
utilizing the in vitro method (Ellman). BtHA inhibited the acetylcholinesterase enzyme competitively (IC50 = 0.6 g/ml); the ethyl acetate fraction (BtF-
AcOEt) caused mixed-type inhibition (IC50 = 0.96 g/ml). A fraction insoluble on methanol (Bt-Faq-1) showed a mixed-type inhibition (CI50 = 0.96 g/ml). 
Finally, the methanol-soluble fraction (Bt-Faq-2), presented complex, mixed-type inhibition that corresponds to the C5 system (  = 0.740 and  = 0.842). 
Rutin, quercetin, kaempferol and ursolic acid were detected by HPLC and the concentration of these compounds was different in each fraction.  
 
Keywords: Bouvardia ternifolia, Acetylcholinesterase, quercetin, rutin, kaempferol, ursolic acid.  
 
Resumen 
El extracto hidroalcohólico (BtHA) y fracciones provenientes de Bouvardia ternifolia fueron evaluadas como inhibidores de la enzima acetilcolinesterasa 
utilizando el método enzimático propuesto por Ellman. BtHA  inhibe a la enzima de manera competitiva (IC50 = 0.6 g/ml); la fracción de acetato de etilo 
(BtF-AcOEt) provoca una inhibición mixta (IC50 = 0.96 g/ml). La fracción insoluble en metanol (Bt-Faq-1) mostró una inhibición tipo mixta (CI50 = 0.96 
g/ml). Finalmente la fracción soluble en metanol, Bt-Faq-2, inhibe a la enzima presentando una inhibición mixta que corresponde a un sistema C5 (  = 0.740 
and  = 0.842). Mediante HPLC se detectó rutina, quercetina, canferol y ácido ursólico la concentración de estos compuestos fue diferente en cada fracción. 
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LISTA DE ABREVIACIONES 
AChE = Acetylcholinesterase enzyme; AD = 
Alzheimer disease; CNS = Central nervous system; 
FDA = Federal Drug Administration; HPLC = High 
Performance Liquid chromatography; PNS = 
Peripheral nervous system; RTs = Retention Times; 
UV = Ultraviolet. 
 
INTRODUCTION 
Due to the chemical complexity of plants and the wide 
variety of associated biological activities, these are 
proposed as alternatives in seeking treatments for 
Alzheimer disease (AD). Some species of the 
Rubiaceae family have been evaluated for their 
capacity to inhibit the Acetylcholinesterase enzyme 
(AChE, EC 3.1.1.7), such as the methanolic extract of 
Paederia linearis Hook (Mukherjee et al., 2007), 
Warszewiczia coccinea (Vahl) Klotzsch, whose 
fractioning led to the isolation of triterpenes with 
AChE inhibitory activity (Calderon et al., 2009). Also, 
the ethyl acetate extract of Morinda citrifolia L. has a 
neuroprotective effect on inhibiting cognitive 
deterioration caused by β-amyloid (25-35), in addition 
to inhibiting AChE (Muralidharan et al., 2010).  
Bouvardia ternifolia (Cav.) Shcltdl 
(Rubiaceae) is native to Mesoamerica and Mexico, 
where it is known as “donita”, “candelilla”, “hierba 
del indio”, “hierba del pasmo”, “trompetilla”, “hierba 
del burro”, and “mirto” (Aguilar-Contreras et al., 
1998; Martínez, 1979). The following are its scientific 
synonyms: Bouvardia angustifolia HBK.; Bouvardia 
hirtella HBK.; Bouvardia jacquinii HBK.; Bouvardia 
linearis HBK.; Bouvardia quaternifolia HBK.; 
Bouvardia tolucana Hook. et. Arn., Bouvardia 
triphylla Salisb. and Houstonia coccinea Andrews 
(Martinez., 1979). 
Peptides have been isolated from this plant 
such as bouvardin, a cyclic hexapeptide made up of 2 
L-alanine, a D-alanine, and 3 modified N-methyl-L-
tyrosines, and which possesses a ring composed of the 
oxidative coupling of the phenolic acid of a tyrosine, 
by the ortho carbon of the phenolic hydroxyl group of 
an adjacent tyrosine, in addition to its deoxy- and 
methylated derivatives (Jolad et al., 1977). It has been 
demonstrated that the leaves of the plant contain a 
high concentration of ursolic and oleanolic acid (Pérez 
et al., 1998). These terpenes possess the following 
properties: sedative, analgesic, hepatoprotective, anti-
inflammatory, antioxidant and AChE-inhibition 
(Cheng et al., 2001), these latter associated with AD. 
Intraperitoneal (i.p.) administration of the methanolic 
extract of B. ternifolia possesses an antitumor effect in 
vivo and cytotoxic activity on tumor cells of 
carcinoma in vitro at a concentration of 20 g/ml 
(Argueta et al., 1994). The hexanic and methanolic 
extracts presented an inhibitory effect on the toxic 
action of Centruroides limpidus limpidus venom in 
mice (Jiménez-Ferrer et al., 2005). In preliminary 
studies, it was demonstrated that bouvardin possesses 
high effectiveness against leukemia P388 and that it is 
slightly active against melanoma B16; these effects 
are carried out due to the inhibition of protein 
synthesis (Johnson et al., 1978). It also exerted an 
effect against the cell division cycle in Chinese 
hamster cells (Tobey et al., 1978).  
In the present work, B. ternifolia was 
evaluated as an AChE inhibitor; this species is broadly 
used in Mexican Traditional Medicine for the 
treatment of neurological diseases caused by rabies 
virus infection or by intoxication with scorpion 
venom. The local population utilizes it for treating 
“the nerves” (an anthropological disease with 
symptoms of restlessness, insomnia, appetite loss, 
cardiac acceleration, and despair), and additionally for 
treating headache and inflammation (Argueta et al., 
1994), the last it is intimately associated with the AD.  
Acetylcholinesterase enzyme (AChE, EC 
3.1.1.7) plays a preponderate role in the activity of the 
central (CNS) and peripheral (PNS) nervous systems 
because it catalyzes the hydrolysis of the 
Acetylcholine neurotransmitter (ACh) (Legay, 2000). 
Alzheimer’s disease (AD) is a neurodegenerative 
disease with high incidence worldwide that mainly 
affects the population aged > 65 years. One of the 
principal factors that lead to dementia is cholinergic 
loss or deficiency (Francis, 2006). AChE is one of the 
main targets of action of drug therapies for this disease 
(Gandía et al., 2006). Some AChE inhibitors such as 
tacrine, physostigmine, donepezil and rivastigmine 
comprise some of the treatments that historically have 
been approved by the Federal Drug Administration 
(FDA) for the treatment of this disorder (Mimica and 
Presecki, 2009). Treatment for patients with AD under 
the AChE inhibition scheme partially delays the 
symptoms associated with cholinergic neurons such as 
memory loss, which is the principal alteration of this 
pathology. Tacrine and physostigmine, the main drugs 
to be approved for the treatment of the symptoms of 
AD, have clinical limitations due their low 
bioavailability and undesirable side effects that 
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accompany a poor effect on memory (Farlow et al., 
1992; Watkins et al., 1994). On the other hand, 
second-generation drugs such as donepezil (FDA-
approved in 1996) present an adequate 
pharmacokinetic profile, but also produce side effects 
such as nausea, vomiting, diarrhea, insomnia, 
gastrointestinal problems, fatigue, and bradycardia, 
which can be associated with its cholinergic activity 
(Roman and Rogers, 2004). In addition to cholinergic 
loss, this disease has other physiopathological 
consequences such as inflammation and oxidative 
stress.  
Because of the use of B. ternifolia in Mexican 
Traditional Medicine and its pharmacological and 
chemical antecedents, in the present work we 
conducted an evaluation of the anti-AChE activity of 
the hydroalcoholic extract and its different fractions, 
as well as its chemical characterization by HPLC.  
 
MATERIALS AND METHODS 
Preparation of aerial parts of B. ternifolia and 
hydroalcoholic extraction 
The aerial parts of B. ternifolia were collected at (19º 
01’ 37.94” N; 99º 12’ 39.57” W to 2589 msnm) 
Coajomulco, Huitzilac, Morelos during the period 
corresponding to September and October 2008. A duly 
identified sample was deposited at the Centro Medico 
Siglo XXI Herbarium (IMSSM) and was authenticated 
by Abigail Aguilar-Contreras, M.Sc., who registered it 
with the number HPMIMSS 13596. The collected 
plant material was dried at room temperature under 
conditions of darkness for 2 weeks. The dry material 
(870 g) was ground to obtain particles with an average 
diameter of 4 mm. This plant material was extracted 
by means of maceration for 2 h with ethanol at 60% at 
a temperature of 50° C (three times). Later, the extract 
was filtered on Whatman #1 paper, retaining the plant 
material to carry out a new extraction under the same 
conditions. The product gathered from the two 
extractions was denominated BtHA. Elimination of 
the solvent was carried out by means of a reduced-
pressure distillation process until obtaining a 
semisolid extract that was finally lyophilized until 
obtaining a solid extract. 
 
Chemical fractionation of the hydroalcoholic extract 
The BtHA (40 g) extract was fractioned through a 
bipartition process with ethyl acetate/water, obtaining 
a low-polarity fraction (BtF-AcOEt, organic) and a 
polar fraction (BtF-Aq, aqueous), which were also 
concentrated to dryness by distillation and lyophilized. 
The BtF-Aq fraction was dissolved in methanol to 
obtain an insoluble amorphous solid and an ochre-
colored solution. The precipitate was denominated Bt-
Faq-1 and the soluble supernatant was named Bt-Faq-
2. 
BtHA and its fractions BtF-AcOEt, Bt-Faq-1, 
and Bt-Faq-2 were utilized for the enzymatic assay; 
thus, they were stored at l4°C for their later use. 
Additionally, these were submitted to analysis by 
HPLC for the chemical characterization based on its 
content of the triterpene ursolic acid (1), as well as of 
the flavonols quercetin (2), rutin (3), and kaempferol 
(4) (Figure 1). 
 
Figure 1 
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Chemical structure of flavonols and ursolic acid 
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Chemical analysis of BtHA and fractions 
We developed an HPLC (High Performance Liquid 
chromatography) method for analysis of rutin, 
quercetin, and kaempferol flavonols using a Waters 
2695 separation-module HPLC system equipped with 
a Waters 996 photodiode array detector and Empower 
Pro software (Waters Corporation, USA). Flavonols 
were separated on a supersphere 100 RP-18 column (4 
 125 mm, 5 µm) (Merck, Darmstadt, Germany). The 
mobile phase consisted of water (pH 3.5, containing 
5% TFA) (solvent A) and acetonitrile (solvent B). The 
gradient system was as follows: 0 - 1 min, 0% B; 2 - 4 
min, 10% B; 5 - 7 min, 20% B; 8 - 14 min, 30% B; 15 
- 18 min, 40% B; 19 - 22 min, 80% B; 23 - 26 min, 
100% B, and 27 - 28 min, 0% B. Flow rate was 
maintained at 1 mL min
-1
 and the injection volume 
was 20 µL. Absorbance was measured at 360 nm. 
Flavonoid peaks were identified by comparison of 
Retention Times (RTs) and Ultraviolet (UV) spectra 
with those of commercial reference compounds. The 
RT for rutin, quercetin and kaempferol was 9.0 min 
(λmax = 205, 250, and 355 nm), 12.3 min (λ = 205, 250 
and 360 nm) and 17.8 min (λ = 205, 250, and 360 
nm), respectively. Amounts of flavonols were 
estimated by interpolation of peak areas and 
comparison with a calibration curve constructed for 
each flavonoid. All analyses were repeated by 
triplicate. Results are expressed as mean values in mg 
g
-1
 dry extracts. 
The same HPLC system and RP-18 column 
were used for quantification of ursolic acid. In this 
case, the gradient system was as follows: 0 - 1 min, 
0% B; 2 - 3 min, 35% B; 4 - 8 min, 45% B; 9 - 12 
min, 70% B; 13 - 14 min, 100% B, and 15 - 18 min, 
0% B. Flow rate was maintained at 1 mL min
-1
 and 
injection volume was 20 µL RT for ursolic acid was 
15.6 min (λmax = 191 nm). 
 
Animals 
Institute of Cancer Research (ICR) albino mice 
weighing 30-36 g were employed (Harlan México, 
DF) and maintained under laboratory conditions at 25º 
C, with a normal 12 h:12 h light/dark schedule (lights 
on at 07:00 a.m.) and free access to water and food 
(pellets from Harlan Rodent Lab Diet). Mice were 
allowed to adapt to the laboratory environment for 3 
weeks before experiments. Experiments were carried 
out between 8:00 a.m. and 12:00 p.m. All studies were 
performed in accordance with official Mexican 
regulation NOM-062-ZOO-1999 (technical 
specifications for the production, care and use of 
laboratory animals). The minimum number of animals 
was employed. 
 
Enzymatic extraction 
Four mice were sacrificed by cervical dislocation and 
the complete brain was obtained immediately. The 
tissue was suspended in 10 mL of phosphate buffer 
150 mM pH 7.2 added to PMFS 
(phenylmethylsulfonyl fluoride, as inhibitor of 
proteases) 0.01% and frozen at -70º C for 24 h. Later, 
the tissue was homogenized in a Potter-type 
homogenizer. The homogenate tissue suspension was 
centrifuged at 14,000 rpm for 10 min and the 
supernatant was utilized as the enzymatic extract, in 
this extract total protein was quantified to maintain a 
constant concentration of these in each assay of 
AChE. 
 
Evaluation of acetylcholinesterase activity in vitro 
Evaluation of acetylcholinesterase activity was 
performed by the method of Ellman et al., (1961), in 
summary, to a final volume of 360 l we added 300 l 
of buffer (100 mM of phosphates pH 8.0), 20 l of 
iodide substrate of acetylthiocholine ATChI (Sigma-
Aldrich, Mexico) in order to adjust the concentration 
to 75, 50, 25, 10 and 5 mM; 20 l of 10 mM of 
Dithio-bis-nitro-benzoate (DTNB) was added and this 
was incubated at 37° C. To initiate the reaction, was 
added 20 l of enzymatic extract and followed the 
reaction at 412 nm, reading the changes in absorbance 
every 20 sec during 3 min. For the inhibition assay, 
additionally solutions of 0.0125, 0.025, 0.05 mg/ml of 
BtHA, BtF-AcOEt, Bt-Faq-1and Bt-Faq-2 dissolved in 
phosphate buffer plus DMSO 5% were utilized. For 
comparison was used tacrine (1,2,3,4-
tetrahydroacridin-9-amine)  to 1 x 10
-5
 M. 
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Figure 2 
 
 
 
Chromatographic analysis by HPLC of fractions from B. ternifolia. BtHA (hydroalcoholic extract), BtF-
AcOEt (ethyl acetate/water, organic fraction), BtF-Aq (ethyl acetate/water, aqueous fraction), Bt-Faq-1 
(precipitate from resuspension of BtF-Aq) and Bt-Faq-2 (soluble fraction from resuspension of BtF-Aq). 
The HPLC Method is specific for flavonoids. Rutin TR = 9.0 min;  
Quercetin TR =13.8; kaempferol TR = 17.7 min 
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Kinetic enzymatic analysis 
To determine enzymatic kinetic parameters, we 
registered changes in absorbance at 405 nm, 
determining initial velocity (V0) as the change in 
Optical density (OD) in 1 min, at which OD is 
transformed into the concentration of the product 
generated utilizing the coefficient of molar extinction 
of 13,600 (Ellman et al., 1961). The kinetic 
parameters of AChE activity in the presence of BtHA, 
BtAcOEt, Bt-Faq-1, and Bt-Faq-2 were analyzed by 
the plot of Lineweaver-Buck and that of Dixon. In 
these are represented the reciprocal of the assay’s 
substrate concentration without inhibitor and the 
growing concentrations of the different extracts. From 
the same figure, it may be interpreted that the 1/V0 
axis intercept of the control assay’s straight line is 
1/Vmax and the slope of the same assay control’s 
straight line is interpreted as Km/Vmax. From the graph 
of the velocity reciprocal vs. the extract’s 
concentration, we were able to obtain the inhibition 
constant (Ki), which coincides with the point at which 
the straight line is intercepted by the axis of the 
extract’s concentration; in addition, with the same 
graph we were able to determine the inhibition type 
generated by each treatment (Trevor, 1981). The IC50 
was calculated with the logarithmic transformation 
graph of the velocity quotient (V/V0-V), where V0 
corresponds to the velocity in the absence of 
treatments and V refers to the velocity in the present 
of treatments (BtHA, BtF-AcOEt, BtF-aq-1, and BtF-
aq-2) vs. the logarithm of the extracts’ or the 
fractions’ concentration; therefore, the value of IC50 
corresponded to the concentration of the extract 
responsible for inhibition at 50% of the enzyme’s 
activity (Giacobini, 1997).  
Figure 3 
 
Chromatographic analysis by HPLC of fractions from B. ternifolia. BtHA (hydroalcoholic extract), BtF-
AcOEt (ethyl acetate/water, organic fraction), Bt-Faq-1 (precipitate from resuspension of BtF-Aq). The 
HPLC Method is specific for Terpenes: ursolic acid TR = 15 min 
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RESULTS 
Hydroalcoholic extraction produced 190 g of whole 
extract (BtHA, 21.8%). Bipartition of 40 g of this 
extract generated 37.5 g of F-Aq and 2.5 of BtF-
AcOEt. Resuspension in methanol of BtF-Aq (20 g) 
produced 2.5 g of the soluble fraction in methanol (Bt-
Faq-1) and 17.5 g of an insoluble precipitate (Bt-Faq-
2). 
Chromatographic analysis by HPLC of the 
whole extract and of the fractions of B. ternifolia 
indicated the presence of the following flavonols: rutin 
(1), quercetin (2), and kaempferol (3). In Figure 2, the 
chromatogram is depicted, which shows the RTs of 
these flavonoids: 9.0 min (λ max = 205, 255 and 355 
nm), 13.8 min (λ max = 209, 255 and 367 nm), and 
17.7 min (λ max = 208, 255 and 367 nm) for rutin, 
quercetin, and kaempferol, respectively. In Figure 3 
the chromatogram shows the presence of ursolic acid 
with an RT of 15 min and a maximal absorption peak 
of 191.0 nm. 
Quantitative analysis of the flavonoids and the 
ursolic acid in the distinct treatments allowed 
determination of the concentration of each chemical 
compound evaluated. Concentration is presented as 
mg of the flavonoid or ursolic acid per gram of the dry 
extract. These amounts are presented in Table 1. 
 
Table 1 
Concentration of flavonoids and ursolic acid, in the hydroalcoholic extract and its fractions  
from B. ternifolia 
 
Fractions from 
 B. ternifolia 
Rutin 
mg/g Ext 
Quercetin  
mg/g Ext 
Kaempferol 
mg/g Ext 
Ursolic acid 
g/g Ext 
BtHA 19.08 16.89 14.66 6.20 
BtF-Aq 17.45 1.88 0.52 Nd 
BtF-AcOEt 4.57 100.27 66.98 68.20 
Bt-Faq-1 87.00 > 0.003 > 0.003 83.93 
Bt-Faq-2 10.53 > 0.003 0.57 Nd 
Nd = undetected; Ext = extract; BtHA (hydroalcoholic extract), BtF-AcOEt (ethyl acetate/water, organic 
fraction), BtF-Aq (ethyl acetate/water, aqueous fraction), Bt-Faq-1 (precipitate from BtF-Aq when was 
dissolved in methanol) and Bt-Faq-2 (soluble fraction). 
 
Tacrine (9-amine-1,2,3,4-tetrahydroacridine) 
was utilized as the assay control of inhibition of AChE 
activity deriving from the mouse brain. In Figure 4 the 
inhibitor effect of tacrine at a concentration of 1 × 10
-5
 
M is depicted (dotted line), where the transformation 
of Lineweaver-Buck has an intersection to the left of 
axis 1/[S]. The tacrine effect was significantly 
different with respect to that inhibitor group (p < 
0.05). 
The effect of B. ternifolia on the activity of 
the acetylcholinesterase enzyme extracted from mouse 
brain, was analyzed using different approximations. 
The former term was employed by the transformation 
of Lineweaver-Buck (Figure 4). In Panel A of Figure 
4, it is shown that the family of straight lines presented 
a point of intersection in the proximity of 1/V0 on the 
right side. The intercept of the straight line without 
inhibitor with the axis of p1/[S] indicated the negative 
inverse value of KM and the straight lines that 
represent the effect of the different concentrations of 
BtHA extract and show the value of apparent KM 
(KMapp); the slope of the straight lines increased the 
concentration of the inhibitor extract. The effect was 
significantly different to high concentrations of BtHA 
respect to data from without inhibitor (p < 0.05). 
BtF-AcOEt at different concentrations caused 
the inhibition that is represented in Figure 4B (and this 
effect was different respect to group without inhibitor, 
p < 0.05), where a family of straight lines is 
represented that has an intersection point to the left of 
1/V0 axis above the 1/[S] axis. This behavior 
corresponds to a mixed inhibition between 
competitive and non-competitive (Segel, 1975). An 
increase presented of the slope in the same manner as 
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the increase in the concentration of the BtF-AcOEt 
extract. 
In Figure 4C, AChE behavior is shown in the 
presence of increasing concentrations of the soluble 
methanol extract, Bt-Faq-2. The point of intersection 
of the family of straight lines is found to the right of 
the 1/V0  axis, where the distance is greater of the point 
of intersection than that exhibited by the BtHA 
extract, indicating a mixed-type inhibition 
corresponding to the C5 system (Segel, 1975), where 
the slope of the straight lines presents a diminution 
with respect to the increase of the inhibitor extract 
concentration, which was statistically different respect 
without inhibitor (p < 0.05). 
In Panel D of Figure 4, the inhibitory effect is 
represented of the precipitate deriving from the 
methanolic extract Bt-Faq-1, demonstrating a family 
of straight lines that has a point of intersection to the 
left of 1/V0 and above 1/[S], which corresponds to a 
mixed inhibition that is intermediate between the 
competitive and the non-competitive types, similar to 
that observed with the BtF-AcOEt fraction. The slope 
of the straight lines increased according to increment 
of the concentration of Bt-AcOEt, which was 
significantly different respect without inhibitor (p < 
0.05). 
 
Figure 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Figure 5, the graphs of 1/V0 vs. [I] of the 
different treatments deriving from B. ternifolia are 
presented, in which the families of straight lines are 
obtained. In Panel A, the effect is presented of the 
different concentrations of the BtHA extract; the 
straight lines exhibit a point of intersection that, on 
being extrapolated to the axis [I], indicated that Ki 
was 204 g/ml of BtHA (Cornish-Bowden, 1974).  
On testing the BtF-AcOEt and Bt-Faq-1 
fractions (Figures 5B and C, respectively), we 
observed a similar behavior between them, with 
analogous points of intersection for both straight-line 
families. The intersection is found in the proximity of 
the axis [I] and to the right of the origin of 1/V0, and 
the Ki for both extracts was 7.01 and 8.24 g/ml, 
respectively. 
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Figure 6 illustrates the behavior of the straight 
lines of the graph of [S]/V0 vs. [I]. In Panel A, the 
effect is presented of BtHA, showing a family of 
parallel lines, which together with that observed in 
Figure 4A, where a point of intersection was obtained 
of the family of straight lines, nearly above the 1/V0 
axis; Figure 2, where the point of intersection of the 
straight-line families is found in the quadrant formed 
by the 1/V0 and –[I] axes, indicates a competitive-type 
inhibition (Cornish-Bowden, 1974). However, because 
BtHA is a complex composition-type extract, it can be 
considered that the effect is concerned with the 
average of the inhibitions shown by the  Bt-Faq-1 
extract, which is mixed type C5 (Figure 4C) and the 
Bt-Faq-2 extract, which is of the mixed type between 
competitive and non-competitive (Figure 4D). Panels 
B and C of Figure 6 present a similar behavior in 
which it is confirmed that the effect observed for 
Figures 4 and 5 and similar to that of Figure 6, for the 
BtF-AcOEt and Bt-Faq-1 extracts, is concerned with 
an intermediate, mixed inhibition between competitive 
and non-competitive behavior (Cornish-Bowden, 
1974). 
Figure 7 is the graphic representation of log10 
(V/V0 – V) vs. log10 [I]. From the extrapolation of 
log10 [I] axis to the point of intersection of the straight-
line family, we calculated the IC50. For BtHA, we 
obtained a value of 0.6 g/ml, as shown in Panel A. In 
Panels B and C, the behavior is shown of BtF-AcOEt 
and Bt-Faq-1, respectively; in both cases, the value of 
IC50 was approximately 0.096 g/ml.  
Finally, Table 2 represents a summary of the 
pharmacokinetic parameters KM (mM), Vmax 
( mol/min), Ki ( g/ml), and IC50 ( g/ml) for each of 
the experimental conditions assayed. 
 
 
 
 
 
 
 
Table 2 
Kinetic constants of Acetylcholinesterase activity from mouse’ brain with B. ternifoli 
. 
 KM
(a) 
mM 
Vmax
(b) 
mol/min 
Ki 
g/ml 
IC50 
g/ml 
Inhibition  
AchE 8.72 2.83x10
-7
    
BtHA
(c)
 11.58 2.94x10
-7
 204.1 0.60 Competitive? 
BtF-AcOEt
(c)
 11.56 2.17x10
-7
 7.0 0.096 Mixed* 
Bt-Faq-1
(c)
 9.85 1.88x10
-7
 8.2 0.096 Mixed* 
Bt-Faq-2
(c)
 2.39 2.06x10
-7
 Nd Nd Mixed** 
Tacrine 8.7 1.70x10
-7
 1.5*** Nd No-competitive 
(a)
The data of KM in presence of inhibitor is corresponding with to apparent KM (KMapp). 
(b) 
 Vmax data in presence of inhibitors corresponding to the maximum velocity inhibited Vmaxi. 
(c)
The concentration used to calculate the constants was 50 g/ml. 
* Mixed inhibition:  intermediate between competitive and non-competitive 
** Mixed inhibition with values defined for  = 0.740 y  = 0.842 
Nd: undetermined 
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Figure 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dixon representation for inhibition of AChE in presence of: A. BtHA (hydroalcoholic extract from B. 
ternifolia); B. BtF-AcOEt (ethyl acetate/water, organic fraction); C. Bt-Faq-1 (precipitate from resuspension 
of BtF-Aq). With increasing concentrations of substrate Acetyl thiocholine iodide: 75 mM,  50 mM,  25 
mM,  10 mM,  5 mM. 
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Figure 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Representation of inhibition of AChE, showed [S]/Vo vs concentration of treatments. In presence of: A. BtHA 
(hydroalcoholic extract from B. ternifolia); B. BtF-AcOEt (ethyl acetate/water, organic fraction); C. Bt-Faq-
1 (precipitate from resuspension of BtF-Aq).  With increasing concentrations of substrate Acetyl thiocholine 
iodide:  75 mM,  50 mM,  25 mM,  10 mM,  5 mM. 
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Figure 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Representation of inhibition of AChE, showed log10(V/Vo-V) vs log10 of concentration of extracts (mg/ml). In 
presence of: A. BtHA (hydroalcoholic extract from B. ternifolia); B. BtF-AcOEt (ethyl acetate/water, organic 
fraction); C. Bt-Faq-1 (precipitate from resuspension of BtF-Aq). With increasing concentrations of 
substrate Acetyl thiocholine iodide: 75 mM,  50 mM,  25 mM,  10 mM,  5 mM. 
 
 
DISCUSSION 
In this work, we report for the first time the inhibitor 
effect of the activity of the AChE activity produced by 
the hydroalcoholic extract of B. ternifolia, and of its 
fractions. The pharmacological characterization of B. 
ternifolia as an acetyl cholinesterase inhibitor arises 
from the traditional use that the communities have 
made of this plant, as a protector from the 
neurological damage associated with different 
pathologies. The increase of AChE activity is a 
physiopathological factor related with memory loss, 
alteration in the speaking capacity and other cognitive 
affectations in AD. This neurodegenerative disorder is 
the most common cause of aging-associated dementia 
and affects 35 million individuals worldwide (Finder, 
2010). Targets have been established for the design of 
drugs for AD treatment, being the most frequently 
employed drugs the group of substances that inhibit 
the AChE enzyme. Despite drugs from this group have 
been approved by the FDA (U.S.), they exhibit 
important adverse side effects; among the prominent 
drugs from this group are tacrine (produces 
hepatotoxicity, nausea, indigestion, vomiting and 
abdominal pain), donepezil (causes headache, fatigue, 
dizziness, nausea, vomiting, weight loss, muscle 
cramping and insomnia), rivastigmine (weight loss, 
anorexia and dizziness), and galantamine (causes 
diarrhea, anorexia, cardiovascular disease, heart attack 
and stroke) (Biran et al., 2009), which has lead to the 
search for medicinal alternatives. 
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Newman and Cragg (2007), mentioned that 
63% of low-weight molecules discovered from 1981-
2006 are natural in origin or are compounds derived 
from natural products. They have been proposed as 
therapeutic resources for the treatment of alterations 
derived from the damage caused by AD because of its 
clinical therapeutic effectiveness as in the case of 
Ginkgo biloba (Gertz and Kiefer, 2004) and its safety 
and tolerability (Andrieu et al., 2003), or due to its 
well-defined pharmacological targets, as is the case of 
galantamine (Heinrich and Teoh, 2004). Successful 
examples of species with anti-AChE activity comprise 
Huperzia serrata (Thunb.) Trevis (Lycopodiaceae), 
from which huperzine has been isolated that inhibits 
this enzyme and improves memory (Ortega et al., 
2004) and Withania somnifera (L) Dunal 
(Solanaceae), from which withanolides with this 
activity have been isolated (Choudhary et al., 2005). 
Of the Rubiaceae family, the alkaloid extract of 
Uncaria rhynchophylla possesses anti-AChE activity 
with a value of 10.8 µg/ml (Yang et al., 2011). This 
species also reduces β-amyloid aggregates (Fujiwara 
et al., 2006).  
Bouvardia ternifolia (Rubiaceae) presented an 
AchE inhibition effect which is demonstrated with the 
analysis of the curves obtained from the reciprocal 
doubles of Lineweaver-Buck; the behavior of the 
whole BtHA extract on AChE follows the complex 
pattern. In the first, analysis of the curved presented in 
Figure 1 indicates that BtHA exercised a competitive-
type inhibition effect, which leads us to think that 
there are one or several compounds in the complex 
mixture that is (are) capable of exercising this activity. 
Analysis by HPLC indicated that this extract possesses 
a chemical profile that includes the presence of 
flavonols such as rutin, quercetin and kaempferol, as 
well as the pentacyclic triterpene, ursolic acid, 
although the content of the latter in BtHA was very 
low; thus, it is probable that inhibition of the enzyme 
caused by this extract is due to the content of 
flavonoids, and above all, quercetin. It has been 
demonstrated that quercetin (a commercial reference) 
exercises a competitive inhibition effect, with a Ki of 
3.79 µM with an IC50 of 353.86 µM in an assay with 
AChE deriving from Torpedo californica. However, 
in this same experiment, rutin and kaempferol 
insignificantly inhibited AChE (Khan et al., 2009). In 
another assay, quercetin at a concentration of 1 mg/ml 
inhibited 76.2% of the activity of the enzyme AChE 
(Orhan et al., 2007). It has also been demonstrated 
that this flavonoid isolated from the Agrimonia pilosa 
Ledeb (Rosaceae) presented an IC50 of 19.8 µM (Jung 
and Park, 2007).  
Later, fractioning of BtHA with ethyl acetate 
and water allowed obtaining of the organic fraction 
(BtF-AcOEt), in which a greater concentration of 
ursolic acid (68.20 µg/g extract) and of flavonoids 
(except for rutin) compared with hydroalcoholic acid 
were identified by HPLC. The BtF-AcOEt fraction, 
with the mixture of flavonoids and ursolic acid, 
exerted intermediate, mixed-type inhibition between 
the competitive and the non-competitive. This 
inhibition type has been reported for ursolic acid 
isolated from Origanum majorana L (Lamiaceae) in 
this study, it was shown that this compound possesses 
the capacity of inhibiting AChE by means of a mixed-
type inhibition (between competitive/non-
competitive), with a Ki of 6 pM (Cheng et al., 2001).   
The BtF-Aq fraction was concentrated and 
resuspended in methanol, obtaining an insoluble 
fraction in methanol (Bt-Faq-1); this fraction varied 
considerably with regard to the concentration of 
flavonoids of which quercetin and kaempferol are 
barely detected, while rutin is at 87 mg/g of extract. 
On the other hand, the separation procedure allowed 
concentration of the fraction toward its content in 
ursolic acid, which rose to 83.93 µg/g extract. This 
fraction exerted an inhibitory effect on the 
intermediate, mixed-type enzyme between competitive 
and non-competitive, which is in agreement with that 
reported in the literature for ursolic acid and with data 
for the BtF-AcOEt fraction. It is probable then that the 
type of effect exercised by Bt-Faq-1 on the enzyme is 
conferred mainly by the terpene, due to the other 
compound found at high concentrations is rutin and, as 
has already been mentioned, according to the 
literature, this substance apparently does not exercise 
significant inhibition on AChE (Khan et al., 2009). 
Separation of the ethyl acetate fraction was 
not only chemical but also allowed for dissociation of 
the type of inhibition exerted by the different groups 
of compounds; thus, the methanol-soluble fraction 
(Bt-Faq-2) exhibited mixed behavior in the enzyme, 
type C5, under the following conditions:  < 1;  < 1, 
and  > . To date, we do not know antecedents in the 
literature on whether flavonols or terpenes exert this 
inhibition. The chemical composition of Bt-Faq-2 
comprises kaempferol and quercetin in scarcely 
detectable concentrations (with the analytical method 
employed) and of rutin of 10 mg/g extract. Ursolic 
acid was not detected. Probably another type of 
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compound makes the inhibition behavior to mixed-
type inhibition, type C5.  
To calculate the inhibition constants of the 
treatments, we utilized the analysis of Dixon; we 
observed (Figure 2) how the BtHA fraction led to 
diminution of the inhibition constant, from 204 µg/ml 
in the whole extract to 7.01 and 8.24 g/ml for BtF-
AcOEt and Bt-Faq-1, respectively, which indicates 
that, on diminishing the chemical complexity of the 
extract, the effect of inhibition is potentialized on the 
enzyme. The Cornish-Bowden (1974) analysis of 
Figures 2 and 3 permits us to effect a more detailed 
description of the behavior of B. ternifolia; in this 
case, we are able to observe that in Figures 2A and 
3A, BtHA in effect exerts competitive-type inhibition 
based on its chemical composition, even if its Ki is 
high. On the other hand, BtF-AcOEt and Bt-Faq-1 
under these conditions also adjust to a mixed inhibitor 
between competitive and non-competitive. On the 
other hand, we carried out the calculation of IC50 with 
the Figure 4 graphs; was detected a value of 0.6 µg/ml 
for the whole extract; this value diminished as the 
purity of the extracts increased. Due to the similarity 
in the chemical composition profile between BtF-
AcOEt and its fraction, Bt-Faq-1, it is possible to 
assume that inhibition of AChE in this system is due 
to the group of low-polarity compounds that includes 
terpenes such as ursolic acid.  
To date, there are no reports on the effects of 
species of the Bouvardia species on neuroprotective 
processes; however, some plants belonging to the 
Rubiaceae have shown as antiacetylcholinesterase 
activity, as in the case of Warszewiczia coccinea, 
whose chemical follow-up led to the structural 
elucidation of two bioactive triterpenes as inhibitors of 
AchE: 3 , 6 , 19 -trihydroxyursolic acid, and 3 , 6 -
dihydroxyoleanolic acid (sumaresinolic acid) 
(Calderón et al., 2009). It is feasible to assume that the 
inhibition effect caused by B. ternifolia is due to its 
high content of ursolic and oleanolic terpenes, from 
which these have separated 80 mg from the former 
and 50 mg from the latter, under a column-
chromatography fractioning scheme that utilized 
ethyl-acetate concentration gradients: chloroform 
(Pérez et al., 1998). Bearing in mind that this plant is 
utilized against inflammatory processes, which in 
addition is accompanied by the demonstration (in this 
work) of anti-AChE activity and the verification that 
within its chemical constitution is found ursolic acid 
with a mixed inhibitory effect on AChE (Cheng et al., 
2001), but in addition possesses important anti-
inflammatory properties together with oleanolic and 
betulinic acid inhibiting the liberation of Interleukin-6 
(IL-6) of a culture of Mono Mac 6 cells (Sabih et al., 
2011) and also is capable of inhibiting 12-O-
tetradecanoylphorbol-13-acetate (TPA)-induced tumor 
promotion in skin (Tozuda et al., 1986). In fact, 
preliminary studies on the BtHA extract of the aerial 
parts of this species induced an anti-inflammatory 
effect in the TPA-induced auricular edema model and 
diminution of cognitive deterioration in mice which 
received scopolamine in the T-form maze test (data 
not shown, 
http://www.relaquim.com/archive/2008/memorias_5_r
eunion_%20prod_nat.pdf). 
 
CONCLUSION 
According to the cholinergic hypothesis and that 
AChE inhibitors improve neuronal transmission 
prolonging the effect of acetylcholine, and with this, 
the temporary diminution of cognitive deterioration, 
B. ternifolia is therefore presented as a plant candidate 
for continuing its study as a potential source of 
compound usefully against the Alzheimer’s disease.  
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